Novartis Recalls Excedrin, Gas-X and Other Popular Brands (Bloomberg Businessweek)

With stray tablets from other products appearing in the over-the-counter medicines, along with broken tablets, Novartis conducted a voluntary recall that could cost the company as much as $750 million.



View the Original article